Annual Drug Patent Expirations for AKEEGA
Akeega is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
Drug patent litigation for AKEEGA.
This drug has two hundred and fifty-six patent family members in fifty-five countries.
The generic ingredient in AKEEGA is abiraterone acetate; niraparib tosylate. One supplier is listed for this compound. Additional details are available on the abiraterone acetate; niraparib tosylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
